Does biology determine survival in pancreatic cancer?

被引：4
|
作者：
Barreto, Savio George [1 ,2 ]
机构：
[1] Flinders Med Ctr, Div Surg & Perioperat Med, Adelaide, SA, Australia
[2] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia
来源：
FUTURE ONCOLOGY | 2020年 / 16卷 / 04期
关键词：
morbidity; mortality; outcomes; survival; ADENOCARCINOMA; RESECTION; HEAD; BODY; IDENTIFICATION; METAANALYSIS; DIVERSITY; EVOLUTION; LOCATION;
D O I：
10.2217/fon-2019-0706
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [1] Does gastrazole improve survival in pancreatic cancer?
    Nature Clinical Practice Oncology, 2006, 3 (7): : 351 - 351
  • [2] DOES GEMZAR IMPROVE SURVIVAL IN RESECTED PANCREATIC CANCER PATIENTS?
    Androutsopoulos, V.
    Dominguez, I.
    Ferrone, C.
    Castillo, C. Fernandez-del
    Warshaw, A. L.
    Thayer, S. P.
    PANCREAS, 2008, 37 (04) : 459 - 459
  • [3] Diagnostic delay does not influence survival of pancreatic cancer patients
    Stornello, Caterina
    Archibugi, Livia
    Stigliano, Serena
    Vanella, Giuseppe
    Graglia, Benedetta
    Capalbo, Carlo
    Nigri, Giuseppe
    Capurso, Gabriele
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (01) : 81 - 90
  • [4] Does extended lymphadenectomy improve survival of pancreatic cancer patients
    Popiela, T
    Kedra, B
    Sierzega, M
    ACTA CHIRURGICA BELGICA, 2002, 102 (02) : 78 - 82
  • [5] Does pancreatic enzyme replacement therapy increase survival in patients with inoperable pancreatic cancer?
    Rutherford, C.
    Ong, K.
    Ballantyne, C.
    Gray, J.
    BRITISH JOURNAL OF SURGERY, 2017, 104 : 32 - 32
  • [6] Body mass index does not affect the survival of pancreatic cancer patients
    Qing-long Jiang
    Cheng-feng Wang
    Yan-tao tian
    Huang Huang
    Shui-Sheng Zhang
    Dong-bing Zhao
    Jie Ma
    Wei Yuan
    Yue-Min Sun
    Xu Che
    Jian-Wei Zhang
    Yun-Mian Chu
    Ya-Wei Zhang
    Ying-tai Chen
    World Journal of Gastroenterology, 2017, (34) : 6287 - 6293
  • [7] Digoxin use is associated with pancreatic cancer risk but does not affect survival
    Boursi, Ben
    Huber, Jared S.
    Haynes, Kevin
    Mamtani, Ronac
    Yang, Yu-Xiao
    CANCER CAUSES & CONTROL, 2021, 32 (01) : 41 - 46
  • [8] Does neoadjuvant therapy improve survival in patients with resectable pancreatic cancer?
    Papalezova, K. T.
    Kim, V. M.
    Stinnett, S. S.
    Blazer, D. G., III
    Clary, B. M.
    Pappas, T. N.
    Tyler, D. S.
    White, R. R.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S70 - S71
  • [9] Does metformin use effect overall survival for patients with pancreatic cancer?
    Ramjeesingh, Ravi
    Nazarali, Samina
    Sheridan, Margaret
    Sun, Peiran
    Popovacki, Aimee
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 660 - 660
  • [10] Digoxin use is associated with pancreatic cancer risk but does not affect survival
    Ben Boursi
    Jared S. Huber
    Kevin Haynes
    Ronac Mamtani
    Yu-Xiao Yang
    Cancer Causes & Control, 2021, 32 : 41 - 46
12345